Company intelligence / Profile preview
Altitude Lab
- Ownership
- Private
- Development stage
- Phase 1
Overview
Altitude Lab provides lab space, funding ($100k–$250k pre-seed investments), mentorship, and entrepreneurial education to early-stage life science startups in Utah. Its supported companies have raised over $154M from 2020–2024. In 2025 it launched the Altitude Lab Fund to bridge federal funding gaps for SBIR/STTR-awarded biotechs
- Industry
- Investors
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Altitude Lab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Altitude Lab.